Literature DB >> 8855194

Portacaval anastomosis induces region-selective alterations of the endogenous opioid system in the rat brain.

J P de Waele1, R M Audet, D K Leong, R F Butterworth.   

Abstract

Portacaval anastomosis (PCA) in the rat results in a broad spectrum of neurological and neurobehavioral changes, including alterations of circadian rhythms, impaired locomotor activity, and reflexes, as well as decreased threshold to noxious stimuli. In addition, following portacaval shunting, rats drink significantly more ethanol in a free-choice drinking paradigm. Available evidence suggests that many of these behavioral changes may be modulated by the endogenous opioid system of the brain. To evaluate this possibility, the effects of PCA on circulating beta-endorphin (beta-EP), as well as beta-EP content in the pituitary and specific brain nuclei, was evaluated using a sensitive radioimmunoassay. Furthermore, the characteristics and regional densities of mu and delta opioid receptors in the brains of PCA and sham-operated control rats were studied using an in vitro technique, as well as quantitative receptor autoradiography and the specific ligands 125I [D-Ala2, MePhe4, Met(o)ol5]enkephalin (FK 33-824) and 125I [2-D-penicillamine, 5-D-penicillamine]-enkephalin (DPDPE) for micro and delta sites, respectively. PCA resulted in region-selective modifications of beta-EP in brain, but not in pituitary or blood. Autoradiographic studies revealed a generalized decrease in mu binding sites (up to 70% decreases compared with sham-operated controls) and region-selective alterations of delta receptor densities following PCA. Portacaval-shunted rats drank significantly more ethanol in a free-choice drinking paradigm, an effect that was significantly attenuated by the administration of the opiate antagonist naloxone. Increased ethanol preference thus appeared to result from modifications of the endogenous opioid system in nucleus accumbens of rats following PCA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855194     DOI: 10.1002/hep.510240423

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

Review 1.  Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

Review 3.  The central opioid system in liver disease and its complications.

Authors:  C Yurdaydin
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

4.  Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Christine M Schubert; Douglas M Heuman; James B Wade; Douglas P Gibson; Allyne Topaz; Kia Saeian; Muhammad Hafeezullah; Debulon E Bell; Richard K Sterling; R Todd Stravitz; Velimir Luketic; Melanie B White; Arun J Sanyal
Journal:  Gastroenterology       Date:  2010-02-20       Impact factor: 22.682

5.  Portacaval anastomosis results in more widespread alterations of cerebral metabolism in old versus young adult rats: implications for post-shunt encephalopathy.

Authors:  R M Audet; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-03       Impact factor: 3.584

Review 6.  Delta Opioid Pharmacology in Relation to Alcohol Behaviors.

Authors:  Doungkamol Alongkronrusmee; Terrance Chiang; Richard M van Rijn
Journal:  Handb Exp Pharmacol       Date:  2018

Review 7.  Antibiotics and Liver Cirrhosis: What the Physicians Need to Know.

Authors:  Caterina Zoratti; Rita Moretti; Lisa Rebuzzi; Irma Valeria Albergati; Antonietta Di Somma; Giuliana Decorti; Stefano Di Bella; Lory Saveria Crocè; Mauro Giuffrè
Journal:  Antibiotics (Basel)       Date:  2021-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.